Advanced company searchLink opens in new window

HD CLINICAL LIMITED

Company number 05436117

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
28 Oct 2024 AA01 Current accounting period extended from 31 October 2024 to 31 December 2024
17 Oct 2024 SH01 Statement of capital following an allotment of shares on 3 October 2024
  • GBP 2,127,497.06
04 Oct 2024 PSC02 Notification of Nexus Ag as a person with significant control on 3 October 2024
04 Oct 2024 PSC07 Cessation of Clive Allan Layton as a person with significant control on 3 October 2024
04 Oct 2024 AP01 Appointment of Mr Ralf Heilig as a director on 3 October 2024
04 Oct 2024 TM01 Termination of appointment of Clive Allan Layton as a director on 3 October 2024
04 Oct 2024 TM01 Termination of appointment of Martin Terry Rothman as a director on 3 October 2024
04 Oct 2024 TM01 Termination of appointment of Charlotte Layton as a director on 3 October 2024
02 Oct 2024 CS01 Confirmation statement made on 20 September 2024 with updates
25 Jul 2024 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES13 ‐ Appointed director 26/03/2018
  • RES01 ‐ Resolution of adoption of Articles of Association
25 Jul 2024 MA Memorandum and Articles of Association
20 Mar 2024 AA Full accounts made up to 31 October 2023
01 Feb 2024 PSC04 Change of details for Dr Clive Allan Layton as a person with significant control on 6 April 2016
15 Jan 2024 SH01 Statement of capital following an allotment of shares on 11 January 2024
  • GBP 2,109,684.22
12 Jan 2024 SH01 Statement of capital following an allotment of shares on 16 October 2023
  • GBP 2,109,071.72
20 Sep 2023 CS01 Confirmation statement made on 20 September 2023 with updates
12 Jun 2023 AA Full accounts made up to 31 October 2022
11 May 2023 SH01 Statement of capital following an allotment of shares on 2 May 2023
  • GBP 2,108,459.22
10 May 2023 CS01 Confirmation statement made on 26 April 2023 with updates
01 Nov 2022 SH01 Statement of capital following an allotment of shares on 3 October 2022
  • GBP 2,103,431.22
27 Apr 2022 CS01 Confirmation statement made on 26 April 2022 with updates
12 Apr 2022 AA Accounts for a small company made up to 31 October 2021
01 Jul 2021 AP01 Appointment of Mr Paul Jonathan Arrowsmith as a director on 1 July 2021
17 Jun 2021 CH01 Director's details changed for Mrs Charlotte Wallden on 17 June 2021
14 Jun 2021 AA Accounts for a small company made up to 31 October 2020